CHCHD2
Coiled-coil-helix-coiled-coil-helix domain-containing protein 2
Also known as: C7orf17, CHCH2_HUMAN, MIX17B, MNRR1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6H1
- Gene
- CHCHD2
- Ensembl
- ENSG00000106153
- Chromosome
- 7
- Canonical length
- 151 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
The protein encoded by this gene belongs to a class of eukaryotic CX(9)C proteins characterized by four cysteine residues spaced ten amino acids apart from one another. These residues form disulfide linkages that define a CHCH fold. In response to stress, the protein translocates from the mitochondrial intermembrane space to the nucleus where it binds to a highly conserved 13 nucleotide oxygen responsive element in the promoter of cytochrome oxidase 4I2, a subunit of the terminal enzyme of the electron transport chain. In concert with recombination signal sequence-binding protein J, binding of this protein activates the oxygen responsive element at four percent oxygen. In addition, it has been shown that this protein is a negative regulator of mitochondria-mediated apoptosis. In response to apoptotic stimuli, mitochondrial levels of this protein decrease, allowing BCL2-associated X protein to oligomerize and activate the caspase cascade. Pseudogenes of this gene are found on multiple chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
151 residues, UniProt reviewed canonical sequence.
>Q9Y6H1|CHCHD2
1 MPRGSRSRTS RMAPPASRAP QMRAAPRPAP VAQPPAAAPP SAVGSSAAAP RQPGLMAQMA
61 TTAAGVAVGS AVGHTLGHAI TGGFSGGSNA EPARPDITYQ EPQGTQPAQQ QQPCLYEIKQ
121 FLECAQNQGD IKLCEGFNEV LKQCRLANGL ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHCHD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 854 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 854 nTPM
- adrenal gland: 738 nTPM
- tongue: 552 nTPM
- choroid plexus: 509 nTPM
- heart muscle: 449 nTPM
- midbrain: 440 nTPM
Single-cell type
- gastric progenitor cells: 1,942 nCPM
- esophageal suprabasal cells: 1,815 nCPM
- esophageal apical cells: 1,808 nCPM
- esophageal basal cells: 1,483 nCPM
- extravillous trophoblasts: 1,473 nCPM
- epididymal principal cells: 1,422 nCPM
Immune cell
- total PBMC: 1,067 nTPM
- plasmacytoid DC: 787 nTPM
- myeloid DC: 577 nTPM
- T-reg: 553 nTPM
- classical monocyte: 510 nTPM
- non-classical monocyte: 470 nTPM
Brain region
- white matter: 325 nTPM
- cerebellum: 311 nTPM
- thalamus: 298 nTPM
- spinal cord: 296 nTPM
- hypothalamus: 294 nTPM
- choroid plexus: 289 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CHCHD2.
Disease | AllUniProt
Conditions CHCHD2 is implicated in, by any mechanism.
- Parkinson disease 22 (PARK22) MIM:616710
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 113 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Parkinson disease 22, autosomal dominant
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.12
- DepMap mean gene effect
- -0.37
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to oxidative stress
- mitochondrion organization
- positive regulation of mitochondrial ATP synthesis coupled electron transport
- positive regulation of transcription by RNA polymerase II
- regulation of cellular response to hypoxia
- regulation of generation of precursor metabolites and energy
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CHCHD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHCHD2 as an antibody target. Whether an autoantibody or antibody against CHCHD2 could matter depends on whether native CHCHD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHCHD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHCHD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...